QuantSignals › Forecasts › NTRA
KATY's daily model path, its record on NTRA, and the options read. Prices as of the Nov 10, 2026 close · page updated Nov 10, 2026.
Last close
$311.98
Nov 10, 2026 · −2.62% on the day
KATY call
SELL
run Nov 6, 2026
Path end (20 sessions)
$286.02
−7.93% from $310.67
Path range
−7.9% to −1.3%
lowest and highest point of the path
Replay record on NTRA
1/1 hits
100% · 0 misses
Options
CHEAP
IV 49% · 0.95× realized
KATY's latest public daily path for Natera, from its run on Nov 6, 2026, points down, which KATY labels SELL. Starting from the $310.67 close, the path ends 20 sessions later near $286.02 (−7.93%), around Dec 4, and ranges between −7.93% and −1.26% along the way. That is a model path, not a price target.
Since that run, NTRA has closed at $311.98 on Nov 10, 2026, +0.42% from the start, 2 of 20 sessions in. So far the move runs against the path. The call is scored after session 20.
On NTRA, KATY's replay record is 1 hits and 0 misses in 1 tested calls (100%), above its 50.1% rate across all tickers. Its most recent completed replay call expected −30.16% and NTRA moved −22.47%: a hit on direction.
In options, the at-the-money 2026-12-18 contract trades at 49% implied volatility against about 52% realized, 0.95× realized, so options read cheap. That is a pricing read, not a signal.
Daily closes, with KATY's Nov 6, 2026 path drawn from its start close to its end point; the shaded wedge spans the path's lowest and highest points.
The KATY apps and extension show the newest NTRA path as soon as it runs, with the full step-by-step line on the chart. They are free to install; live forecasts need KATY Premium or an FST membership.
Every public NTRA path this page has captured, scored on the close 20 sessions after its start: a BUY is a hit if that close is higher, a SELL if it is lower.
| Run | Call | Start close | Path end | Outcome at 20 sessions |
|---|---|---|---|---|
| Nov 6, 2026 | SELL | $310.67 | $286.02 (−7.93%) | Open, 2/20 sessions · +0.42% so far |
1 hits, 0 misses in 1 replayed NTRA calls (100% on direction; 100% finished inside the 1.5% band; average path error 18.32%). Across all tickers KATY's replay hit rate is 50.1% over 1,023 calls (BUY > +1.5%, SELL < -1.5% on the 20-step path). Replays re-run the model on past data it did not see; they are not live trades.
KATY re-forecast the 20 sessions that just finished without seeing them. It expected −30.16%; the actual move was −22.47% (direction hit, average path error 18.32%).
| Step | Session | Model path | Actual close | Path vs actual |
|---|---|---|---|---|
| 1 | Oct 12, 2026 | $386.38 | $397.77 | −2.86% |
| 5 | Oct 16, 2026 | $346.35 | $393.44 | −11.97% |
| 10 | Oct 23, 2026 | $322.59 | $403.95 | −20.14% |
| 15 | Oct 30, 2026 | $301.21 | $414.30 | −27.30% |
| 20 | Nov 6, 2026 | $279.86 | $310.67 | −9.92% |
The at-the-money 2026-12-18 NTRA option (38 days) is priced at 49.2% implied volatility, 0.95× the stock's realized volatility, which reads cheap. Cheap or rich is a pricing read, not a signal. See the full options-value screen.
KATY's latest public daily path for NTRA (run Nov 6, 2026) is SELL: from $310.67 it ends near $286.02 (−7.93%) after 20 sessions. It is a model path, not a price target. The newest path is in the KATY apps (free to install; live forecasts need KATY Premium or an FST membership).
In replay, KATY called the direction of NTRA right 1 times and wrong 0 times out of 1 tested calls (100%). Public calls on this page are scored after 20 sessions and listed above, misses included.
KATY is a time-series foundation model that reads the recent daily bars of NTRA and draws the most likely path for the next 20 sessions. A path that ends more than 1.5% up is a BUY, more than 1.5% down a SELL, and anything in between is NEUTRAL. It is not investment advice.
KATY draws this forecast on your own charts: in TradingView with the Chrome extension, or on your phone. The extension and apps are free to install; live forecasts need KATY Premium or an FST membership.
Healthcare & biotech
Most viewed
Not investment advice. KATY's output is a model path, not a price target and not a recommendation to buy or sell. Model forecasts are often wrong; the hit and miss counts on this page are shown so you can judge that yourself. Trading involves risk of loss. Data from QS Research; prices are daily closes and may lag.